Stunning video by Canadian doctors shows how Pfizer committed massive fraud during COVID-19 vaccine trials

[g]

A group of Canadian doctors has painstakingly demonstrated how Pfizer committed monumental fraud in conducting rapid clinical trials of its COVID-19 vaccine as they present evidence refuting nearly all claims that the jab is safer and that getting one reduces the incidence and seriousness of the coronavirus.

The organisation called the Canadian COVID Care Alliance, representing more than 500 independent Canadian doctors, scientists and health care practitioners, presented a 40-minute video and accompanying slide presentation explaining exactly how Pfizer fudged numbers and testing in order to get its shot approved quickly under a program launched by former President Donald Trump, who very likely had no idea what the big pharma giant had done when his administration green-lighted Pfizer’s mRNA vaccinefor emergency authorisation.

In short, according to The COVID World, “The full 40-minute video presentation by the group includes PDF slides that show evidence that Pfizer misrepresented data to hide the fact that their COVID injections came with an increased risk of illness and death when compared to the placebo group in their trial.”

The presentation “explains how Pfizer failed to follow established, high-quality safety and efficacy protocols for vaccine development as everything was done in under a year and animal testing was skipped,” the website adds.

The organisation also highlights how Pfizer allegedly minimised vaccine injury to Maddie de Garay, a teen who was paralysed from the waist down after she took part in a clinical trial for 12-to-15-year-olds in December 2020, noting that she still requires a wheelchair in order to get around and that she needs a feeding tube more than a year after the trial ended.

The presentation begins by noting that the best empirical evidence when conducting vaccine and other medicinal trials is “Level 1 evidence,” which is the “gold standard” and the only way that something can actually be proven true. As such, when making public health policy, only Level 1 evidence should be utilised.

But that wasn’t the case when it came to Pfizer’s vaccine, at least. The company said in its original trial report dated Dec. 31, 2020, after just two months’ worth of randomised testing — the appropriate way to test medication efficacy — that its vaccine had an efficacy rate of 95 percent seven days after the second dose, but further examination found that to be a gross exaggeration.



In reality, the 95-percent rate reflects “relative risk reduction,” but the “absolute risk reduction,” the more important metric, showed that the vaccine only carried a .84 percent efficacy rate.